22nd Euretina 2022 Congress Hamburg, September 1 – 4th Ossi Leppänen2022-09-14T09:32:00+02:00June 26th, 2022| Read More
Controlled & Modified Drug Release Summit 2022, August 23-24 Ossi Leppänen2022-06-09T20:40:41+02:00June 9th, 2022| Read More
13th Drug Delivery & Formulation Summit Berlin June, 27-29 Ossi Leppänen2022-06-07T11:32:29+02:00June 7th, 2022| Read More
DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology Ossi Leppänen2022-05-18T11:21:41+02:00May 18th, 2022| Read More
DelSiTech is recruiting highly motivated drug development professionals for exciting key positions at the company facility in Turku, Finland. Ossi Leppänen2022-05-13T14:04:23+02:00May 13th, 2022| Read More
BIO International Convention San Diego June, 13-16 Ossi Leppänen2022-05-06T16:13:17+02:00May 6th, 2022| Read More
6th international Conference on Drug Delivery and Formulations 2022 Edinburgh, May 18-19 Ossi Leppänen2022-04-06T18:36:43+02:00April 6th, 2022| Read More
DelSiTech to Present at ARVO 2022 Denver, May 1-4 Ossi Leppänen2022-04-06T18:05:31+02:00April 6th, 2022| Read More
CRS LNP-RNA Therapeutics Symposium 2022, April 6-7 Ossi Leppänen2022-04-06T16:42:59+02:00April 6th, 2022| Read More
DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics for the Development of a Controlled Release Ophthalmic Eye Drop Product Ossi Leppänen2022-03-28T11:32:06+02:00March 28th, 2022| Read More
